BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 546575)

  • 1. [Hepatic damage caused by drugs and evaluation of the therapeutic effectiveness of pyridoxine pyrrolidone carboxylate].
    Nami R
    Clin Ter; 1979 Oct; 91(1):41-55. PubMed ID: 546575
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of alcoholic hepatic steatosis with metadoxine. Preliminary results on the evaluation of the effects of the drug by an ultrasonographic study].
    Sergiacomo L; Ciancaglini R; Orlando D; Delle Monache G; Pesa O
    Clin Ter; 1986 Oct; 119(2):133-41. PubMed ID: 3539468
    [No Abstract]   [Full Text] [Related]  

  • 3. [The therapeutic effect of metadoxine on alcoholic and non-alcoholic steatohepatitis].
    Váli L; Blázovics A; Fehér J
    Orv Hetil; 2005 Nov; 146(47):2409-14. PubMed ID: 16398154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapy of hyperammonemia: effect of a preparation arginine pyrrolidonecarboxylate, taurine, vitamin B6 and citric acid].
    Verzetti G; Emanuelli G; Montagnani M
    Clin Ter; 1972 Mar; 60(5):429-38. PubMed ID: 5038775
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapeutic use of metadoxine in alcohol-related mental and behavioral disorders].
    Carboni MA; Corsa R
    Clin Ter; 1987 Dec; 123(6):469-73. PubMed ID: 2972505
    [No Abstract]   [Full Text] [Related]  

  • 6. Therapeutic contribution of pyrodoxine pyrrolidinecarboxylate. (Notes on antiseborrheic treatment).
    Ghittoni S; Orsucci O; Saviozzi A; Simonini P
    Ital Gen Rev Dermatol; 1978; 15(1):39-61. PubMed ID: 162287
    [No Abstract]   [Full Text] [Related]  

  • 7. [Metadoxine in the control of oxidative stress caused by acute and chronic ethanol poisoning].
    Calabrese V; de Bernardis E; Rizza V
    Boll Soc Ital Biol Sper; 1986 Nov; 62(11):1357-63. PubMed ID: 3828134
    [No Abstract]   [Full Text] [Related]  

  • 8. [Metadoxine in the treatment of vomiting in uremic patients under dialysis treatment].
    Di Paolo N; De Mia M; Gaggiotti E
    Clin Ter; 1984 Aug; 110(3):221-9. PubMed ID: 6237861
    [No Abstract]   [Full Text] [Related]  

  • 9. [Metadoxine in alcohol-related pathology].
    Santoni S; Corradini P; Zocchi M; Camarri F
    Clin Ter; 1989 Jul; 130(2):115-22. PubMed ID: 2529084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of pyrrolidone carboxylate (PCA) and pyridoxine on liver metabolism during chronic ethanol intake in rats.
    Calabrese V; Ragusa N; Rizza V
    Int J Tissue React; 1995; 17(1):15-20. PubMed ID: 7499060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment with metadoxine and its impact on early mortality in patients with severe alcoholic hepatitis.
    Higuera-de la Tijera F; Servín-Caamaño AI; Cruz-Herrera J; Serralde-Zúñiga AE; Abdo-Francis JM; Gutiérrez-Reyes G; Pérez-Hernández JL
    Ann Hepatol; 2014; 13(3):343-52. PubMed ID: 24756009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapeutic effectiveness of thiazolidinecarboxylate of arginine in psychiatric patients with hepatic disorders of toxic origin (alcohol, drugs)].
    Trasatti GA; Ripani G
    Clin Ter; 1979 Nov; 91(4):395-405. PubMed ID: 540484
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of pyridoxine-pyrrolidone-carboxylate on hepatic adenosine triphosphate levels in rats.
    Baldacci M; Catalani R; Bartoli C; Mura U
    Boll Soc Ital Biol Sper; 1982 Dec; 58(24):1643-9. PubMed ID: 7168788
    [No Abstract]   [Full Text] [Related]  

  • 14. Alcoholic abstinence syndrome: short-term treatment with metadoxine.
    Bono G; Sinforiani E; Merlo P; Belloni G; Soldati M; Gelso E
    Int J Clin Pharmacol Res; 1991; 11(1):35-40. PubMed ID: 1678735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Metadoxyl in combined treatment of alcohol damage to the liver].
    Vedrova NN; Gnezdilova NIu
    Klin Med (Mosk); 2001; 79(4):56-8. PubMed ID: 11496744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Blood ammonia antagonistic and hepatoprotective effect of a combination of arginine, taurine and vitamin B6 pyrrolidon-carboxylate].
    Di Rosa M
    Clin Ter; 1967 Sep; 42(6):499-507. PubMed ID: 5618919
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of pyridoxine-pyrrolidon-carboxylate on hepatic and cerebral ATP levels in ethanol treated rats.
    Felicioli R; Saracchi I; Flagiello AM; Bartoli C
    Int J Clin Pharmacol Ther Toxicol; 1980 Jun; 18(6):277-80. PubMed ID: 7192694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of alcoholic fatty liver: is the metabolic effect of metadoxine the only reason for improved liver function?
    Stefanini GF; Addolorato G; Caputo F; Bernardi M; Gasbarrini G
    J Hepatol; 1999 Apr; 30(4):739-40. PubMed ID: 10207820
    [No Abstract]   [Full Text] [Related]  

  • 19. [Non-alcoholic fatty liver disease: age peculiarities, breakthrough in pathogenetic therapy].
    Pal'tsev AI; Sharapov IV; Gorbunova EN; Khomchenko TN; Kurganova IV; Soldatova GS; Eremina AA; Nikolaev IuA
    Eksp Klin Gastroenterol; 2009; (8):19-25. PubMed ID: 20469674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The value of magnesium pyrrolidone carboxylate in true cervix dystocia. A double blind versus placebo study].
    Demory JE; Firmin JM; Parot P
    Rev Fr Gynecol Obstet; 1990 Jun; 85(6):413-6. PubMed ID: 2389112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.